Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome
L Gallimberti, M Cibin, P Pagnin, R Sabbion… - …, 1993 - nature.com
Abstract
In a double-blind placebo-controlled trial, gamma-hydroxybutyric acid (GHB)(25 mg/kg orally) suppressed most of the withdrawal symptomatology in 14 heroin addicts and 13 methadone-maintained subjects. The GHB effect was prompt (within 15 minutes) and …
Last updated: Oct 15, 2020